Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transfusion-associated AIDS.

H A Perkins

    American Journal of Hematology
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Acquired Immunodeficiency Disease (AIDS) transmission via blood transfusion is rare but possible. Blood banks are implementing new antibody testing to reduce the risk of transfusion-associated AIDS.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Acute anemic events in sickle cell disease.

    Transfusion·2000
    Same author

    Heterosexual transmission of human immunodeficiency virus type 1 from transfusion recipients to their sex partners.

    Journal of acquired immune deficiency syndromes·1994
    Same author

    Declining efficacy of AIDS case list cross-referencing in human immunodeficiency virus look-back: 1981 through 1992.

    Transfusion·1994
    Same author

    The U.S. National Marrow Donor Program.

    The American journal of pediatric hematology/oncology·1994
    Same author

    Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program.

    Clinical transplants·1994
    Same author

    Is white cell reduction cost-effective?

    Transfusion·1993
    Same journal

    Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.

    American journal of hematology·2026
    Same journal

    Comparative Efficacy of Intranasal, Intramuscular, and Intravenous Vitamin B12 Therapy for Hematological Recovery in Vitamin B12 Deficiency Anemia: A Randomized Controlled Trial.

    American journal of hematology·2026
    Same journal

    Clinical Predictors of Response in Chronic Graft-Versus-Host Disease: Results From the "Predicting the Quality of Response to Specific Treatments (PQRST)" Trial.

    American journal of hematology·2026
    Same journal

    Relapse Thresholds (12/24 Mo) Define Survival Disparity in Pediatric B-ALL.

    American journal of hematology·2026
    Same journal

    Quizartinib in Combination With FLAG-IDA for Relapsed or Refractory Acute Myeloid Leukemia (FLAG-QUIDA): A PETHEMA Phase I-II Trial.

    American journal of hematology·2026
    Same journal

    Defining a Subgroup of Myelodysplastic Syndrome Patients With Very Poor-Risk Cytogenetics Demonstrating a Relatively More Favorable Outcome After Allogeneic Hematopoietic Cell Transplantation.

    American journal of hematology·2026
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Hematology
    • Public Health

    Background:

    • Blood transfusion carries a minimal risk of transmitting Acquired Immunodeficiency Disease (AIDS).
    • Understanding transmission routes and donor risk factors is crucial for blood safety.
    • Previous screening methods had limitations in detecting the causative virus.

    Purpose of the Study:

    • To review evidence on AIDS transmission through blood transfusion.
    • To assess transfusion risks in various scenarios.
    • To outline preventative measures by blood banks.

    Main Methods:

    • Literature review of transfusion-associated AIDS cases.
    • Analysis of risk factors in different transfusion situations.
    • Examination of blood bank screening protocols.

    Related Experiment Videos

    Main Results:

    • Evidence confirms rare transmission of AIDS via blood components.
    • Specific situations and donor groups pose varying risks.
    • Blood banks are actively implementing donor screening and preventative strategies.

    Conclusions:

    • While the risk is extremely low, vigilance in blood transfusion safety is essential.
    • The introduction of Human T-lymphotropic virus type III (HTLV-III) antibody testing is a key advancement.
    • Further evaluation of HTLV-III test accuracy in blood donors is needed.